Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 (Re)defining biopharmaceutical.

Literature DB >> 18612293

(Re)defining biopharmaceutical.

Abstract

Vested interests are redefining, rebranding and co-opting what is 'biopharmaceutical'. This is not just a matter of semantics-the core identity of the biotech industry and its products is at stake.

Mesh：

Year: 2008 PMID： 18612293 DOI： 10.1038/nbt0708-743

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

Keyword Cloud
Cited

24 in total

Review 1. The cost-effectiveness of biopharmaceuticals: a look at the evidence.

Authors: Andrew W Wilson; Peter J Neumann
Journal: MAbs Date: 2012-03-01 Impact factor: 5.857

2. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Authors: Damian Houde; Steven A Berkowitz; John R Engen
Journal: J Pharm Sci Date: 2010-12-29 Impact factor: 3.534

3. Characterizing monoclonal antibody structure by carboxyl group footprinting.

Authors: Parminder Kaur; Sara E Tomechko; Janna Kiselar; Wuxian Shi; Galahad Deperalta; Aaron T Wecksler; Giridharan Gokulrangan; Victor Ling; Mark R Chance
Journal: MAbs Date: 2015 Impact factor: 5.857

4. Characterizing monoclonal antibody structure by carbodiimide/GEE footprinting.

Authors: Parminder Kaur; Sara Tomechko; Janna Kiselar; Wuxian Shi; Galahad Deperalta; Aaron T Wecksler; Giridharan Gokulrangan; Victor Ling; Mark R Chance
Journal: MAbs Date: 2014 Impact factor: 5.857

5. Nanofluidic device for continuous multiparameter quality assurance of biologics.

Authors: Sung Hee Ko; Divya Chandra; Wei Ouyang; Taehong Kwon; Pankaj Karande; Jongyoon Han
Journal: Nat Nanotechnol Date: 2017-05-22 Impact factor: 39.213

6. Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part I--a method of manual documentary analysis.

Authors: Nina Ilic; Snezana Savic; Evan Siegel; Kerry Atkinson; Ljiljana Tasic
Journal: Stem Cells Transl Med Date: 2012-12-04 Impact factor: 6.940

(Re)defining biopharmaceutical.

Review 1. The cost-effectiveness of biopharmaceuticals: a look at the evidence.

2. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

3. Characterizing monoclonal antibody structure by carboxyl group footprinting.

4. Characterizing monoclonal antibody structure by carbodiimide/GEE footprinting.

5. Nanofluidic device for continuous multiparameter quality assurance of biologics.

6. Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part I--a method of manual documentary analysis.

Review 7. Recent Advances in Application of Pharmacogenomics for Biotherapeutics.

8. Antibodies and other biopharmaceuticals.

Review 9. Extrinsic regulation of satellite cell specification.

Review 10. Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust.